当前位置:首页 - 行情中心 - 济民医疗(603222) - 财务分析 - 利润表

济民医疗

(603222)

  

流通市值:33.74亿  总市值:33.74亿
流通股本:5.37亿   总股本:5.37亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入677,627,000.76444,342,730.58222,593,735.45837,236,200.99
营业收入677,627,000.76444,342,730.58222,593,735.45837,236,200.99
二、营业总成本619,320,318.07393,448,796.9180,569,449.78770,554,709.66
营业成本379,217,727.2244,735,942.7117,911,238.48449,730,115.53
税金及附加8,968,390.995,637,583.252,571,558.2211,642,686.73
销售费用120,506,164.8873,163,388.426,635,552.07158,797,382.42
管理费用74,175,692.9746,655,523.9822,143,192.37100,163,021.28
研发费用21,841,589.3413,593,441.726,259,247.5728,378,222.73
财务费用14,610,752.699,662,916.855,048,661.0721,843,280.97
其中:利息费用17,184,258.4410,465,635.925,297,44029,442,778.88
其中:利息收入3,260,670.842,230,143.691,318,730.692,598,160.98
加:投资收益3,519,169.95876,703.88-3,575.859,374,607.73
资产处置收益-810,330.868,739.23276.6932,854.96
资产减值损失(新)972,237.41818,326.97619,535.55-11,383,159.68
信用减值损失(新)-2,196,345828,354.33,383,128.29-34,748,799.7
其他收益8,551,061.036,447,050.861,431,830.2716,011,764.87
营业利润平衡项目0000
四、营业利润68,342,475.2259,873,108.9247,455,480.6245,968,759.51
加:营业外收入56,695.5220,795.4520,000.39156,790.87
减:营业外支出3,779,959.933,508,996.1677,332.363,186,425.77
利润总额平衡项目0000
五、利润总额64,619,210.8156,384,908.2147,398,148.6542,939,124.61
减:所得税费用3,269,766.423,311,618.573,860,879.4816,805,162.98
六、净利润61,349,444.3953,073,289.6443,537,269.1726,133,961.63
持续经营净利润61,349,444.3953,073,289.6443,537,269.1726,133,961.63
归属于母公司股东的净利润45,076,348.0439,232,780.8433,728,551.4234,469,017.05
少数股东损益16,273,096.3513,840,508.89,808,717.75-8,335,055.42
(一)基本每股收益0.080.070.060.07
(二)稀释每股收益0.080.070.060.07
八、其他综合收益1,836,156.734,991,419.6807,638.372,327,229.77
归属于母公司股东的其他综合收益1,836,156.734,991,419.6807,638.372,327,229.77
九、综合收益总额63,185,601.1258,064,709.2444,344,907.5428,461,191.4
归属于母公司股东的综合收益总额46,912,504.7744,224,200.4434,536,189.7936,796,246.82
归属于少数股东的综合收益总额16,273,096.3513,840,508.89,808,717.75-8,335,055.42
公告日期2023-10-312023-07-252023-04-282023-04-20
审计意见(境内)标准无保留意见
TOP↑